BGLC Financial Model
Quarterly and annual income statement, cash flow and balance sheet line items for BioNexus Gene Lab Corp Common stock: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding. Latest statement: Jun 30, 2026.